Vir Biotechnology to Provide Business Update and Report Second Quarter 2023 Financial Results on August 3, 2023GlobeNewsWire • 07/26/23
Vir Biotechnology says mid-stage trial of a flu treatment failed to meet main goalsMarket Watch • 07/20/23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating VIR-2482 for the Prevention of Seasonal Influenza A IllnessGlobeNewsWire • 07/20/23
Vir Biotechnology Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs OfficerGlobeNewsWire • 06/29/23
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023PRNewsWire • 06/25/23
Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 as Therapies for Chronic Hepatitis B and Hepatitis DGlobeNewsWire • 06/24/23
Vir Biotechnology Unveils Hidden Value: Innovation, Strategic Partnerships Drive Investment PotentialSeeking Alpha • 06/13/23
Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023GlobeNewsWire • 06/07/23
Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare ConferenceGlobeNewsWire • 06/05/23
Vir Biotechnology Appoints Jeff Calcagno, M.D., as Executive Vice President and Chief Business OfficerGlobeNewsWire • 05/15/23
Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTIGlobeNewsWire • 05/11/23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial ResultsGlobeNewsWire • 05/04/23
Vir Biotechnology to Participate in the BofA Securities 2023 Health Care ConferenceGlobeNewsWire • 05/03/23
Vir Biotechnology Receives Expanded Support to Develop Its Novel T Cell Vaccine Platform with New $10 Million Grant for HIV PreventionGlobeNewsWire • 05/02/23
Earnings Preview: Vir Biotechnology, Inc. (VIR) Q1 Earnings Expected to DeclineZacks Investment Research • 04/27/23
Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/11/23
Is the Options Market Predicting a Spike in Vir Biotechnology (VIR) Stock?Zacks Investment Research • 03/29/23